Volume 21 - Issue 7 - July 2013
Cover Story
07/22/2013
Cosmeceuticals have the potential to benefit a multitude of patients. Utilizing the science behind the products will enable the dermatology provider to offer all patients a cosmeceutical regimen that is tailored to individual...
Cosmeceuticals have the potential to benefit a multitude of patients. Utilizing the science behind the products will enable the dermatology provider to offer all patients a cosmeceutical regimen that is tailored to individual...
Cosmeceuticals have the...
07/22/2013
The Dermatologist
04/07/2016
Biologics remain an expensive class of drugs, as they account for one-fourth of what Americans spend on medications each year, marking their importance in the managed care arena.
Biologics remain an expensive class of drugs, as they account for one-fourth of what Americans spend on medications each year, marking their importance in the managed care arena.
Biologics remain an expensive...
04/07/2016
The Dermatologist
04/07/2016
The emergence of biologic therapies has changed the way dermatologists treat many chronic cutaneous diseases.
The emergence of biologic therapies has changed the way dermatologists treat many chronic cutaneous diseases.
The emergence of biologic...
04/07/2016
The Dermatologist
04/07/2016
The review of several long-term safety evaluations of ustekinumab supports the assertions of short-term studies that indicate this biologic as favorable for the treatment of psoriasis. These long-term analyses included 3,117 patients who...
The review of several long-term safety evaluations of ustekinumab supports the assertions of short-term studies that indicate this biologic as favorable for the treatment of psoriasis. These long-term analyses included 3,117 patients who...
The review of several long-term...
04/07/2016
The Dermatologist
04/07/2016
Sensitive biomarkers help determine early changes in those with psoriatic arthritis (PsA). Marjan de Groot, MD, and colleagues published a study in Dermatology in 2012 that determined which changes in the skin best correlate with clinical...
Sensitive biomarkers help determine early changes in those with psoriatic arthritis (PsA). Marjan de Groot, MD, and colleagues published a study in Dermatology in 2012 that determined which changes in the skin best correlate with clinical...
Sensitive biomarkers help...
04/07/2016
The Dermatologist
04/07/2016
Biologic treatment for skin infammation in psoriasis leads to improvement, but its effect on vascular infammation is less defned. Robert Bissonnette, MD, FRCPC, and col- leagues published a study in Circulation: Cardiovascular Imaging in...
Biologic treatment for skin infammation in psoriasis leads to improvement, but its effect on vascular infammation is less defned. Robert Bissonnette, MD, FRCPC, and col- leagues published a study in Circulation: Cardiovascular Imaging in...
Biologic treatment for skin...
04/07/2016
The Dermatologist
04/07/2016
In a study published in 2013 in British Journal of Dermatology, Paolo Gisondi, MD, and colleagues observed the difference in the effects that the biologic agents ustekinumab and infiximab have on patients body mass index (BMI). When...
In a study published in 2013 in British Journal of Dermatology, Paolo Gisondi, MD, and colleagues observed the difference in the effects that the biologic agents ustekinumab and infiximab have on patients body mass index (BMI). When...
In a study published in 2013 in...
04/07/2016
The Dermatologist
04/07/2016
A systematic review conducted by Slaven Sikirica, published in Value in Health in 2013, confrmed that psoriasis patients with an improvement of a minimally important difference (MID) in their health-related quality of life (QOL), as...
A systematic review conducted by Slaven Sikirica, published in Value in Health in 2013, confrmed that psoriasis patients with an improvement of a minimally important difference (MID) in their health-related quality of life (QOL), as...
A systematic review conducted by...
04/07/2016
The Dermatologist
04/07/2016
Psoriasis is a condition that is known to reduce work productivity, and many biologic treatments lack a suffcient amount of evidence regarding their role in improving work output. In a recent study conducted in Canada and published in...
Psoriasis is a condition that is known to reduce work productivity, and many biologic treatments lack a suffcient amount of evidence regarding their role in improving work output. In a recent study conducted in Canada and published in...
Psoriasis is a condition that is...
04/07/2016
The Dermatologist
04/07/2016
A study published in February 2013 in Journal of the European Academy of Dermatology and Venereology states that, for those with moderate-to-severe psoriasis being treated with biologics, a reduction of Psoriasis Area and Severity Index...
A study published in February 2013 in Journal of the European Academy of Dermatology and Venereology states that, for those with moderate-to-severe psoriasis being treated with biologics, a reduction of Psoriasis Area and Severity Index...
A study published in February...
04/07/2016
The Dermatologist
04/07/2016
Almost 50% of psoriasis patients report a disturbance in their sleep at least once a month due to their condition. This sleep defciency can be attributed to a number of related symptoms, including pain and emotional disturbances. A study by...
Almost 50% of psoriasis patients report a disturbance in their sleep at least once a month due to their condition. This sleep defciency can be attributed to a number of related symptoms, including pain and emotional disturbances. A study by...
Almost 50% of psoriasis patients...
04/07/2016
The Dermatologist
